Partial growth hormone deficiency and changed bone quality and mass in type I trichorhinophalangeal syndrome
- PMID: 18478599
- DOI: 10.1002/ajmg.a.32348
Partial growth hormone deficiency and changed bone quality and mass in type I trichorhinophalangeal syndrome
Erratum in
- Am J Med Genet A. 2009 Feb;149A(2):296
Abstract
The trichorhinophalangeal syndromes (TRPSs) are syndromes due to haploinsufficiency of genes in the chromosome 8q24.12 region. Type I TRPS is characterized by typical facial features including sparse, brittle and fine hair, bulbous nose, and a long philtrum, as well as skeletal abnormalities. Growth retardation is a feature frequently found in these patients, who commonly are of short stature; however, only one case with growth hormone deficiency has been described in a TRPS patient and that patient had type II TRPS. Skeletal morphological abnormalities have been studied, but investigation of bone metabolism and quality in this kind of patients are not available. In this report we describe two cases of type I TRPS with partial growth hormone deficiency and significant bone mass and quality impairment, which was unresponsive to GH treatment.
2008 Wiley-Liss, Inc.
Similar articles
-
Recombinant Human Growth Hormone Therapy for Childhood Trichorhinophalangeal Syndrome Type I: A Case Report.Children (Basel). 2022 Sep 22;9(10):1447. doi: 10.3390/children9101447. Children (Basel). 2022. PMID: 36291383 Free PMC article.
-
Trichorhinophalangeal syndrome, type I.J Am Acad Dermatol. 1994 Aug;31(2 Pt 2):331-6. doi: 10.1016/s0190-9622(94)70166-0. J Am Acad Dermatol. 1994. PMID: 8034799 Review.
-
Should Patients with Trichorhinophalangeal Syndrome be Tested for Growth Hormone Deficiency?Pediatr Endocrinol Rev. 2015 Sep;13(1):465-7. Pediatr Endocrinol Rev. 2015. PMID: 26540763
-
Clinical and molecular characterization of a patient with Langer-Giedion syndrome and mosaic del(8)(q22.3q24.13).Am J Med Genet A. 2008 Dec 15;146A(24):3211-6. doi: 10.1002/ajmg.a.32615. Am J Med Genet A. 2008. PMID: 19012352
-
An early diagnosis of trichorhinophalangeal syndrome type 1: a case report and a review of literature.Ital J Pediatr. 2018 Nov 20;44(1):138. doi: 10.1186/s13052-018-0580-z. Ital J Pediatr. 2018. PMID: 30458885 Free PMC article. Review.
Cited by
-
What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.BMC Med Genet. 2018 Mar 2;19(1):32. doi: 10.1186/s12881-018-0530-z. BMC Med Genet. 2018. PMID: 29499646 Free PMC article.
-
Severe brachydactyly and short stature resulting from a novel pathogenic TRPS1 variant within the GATA DNA-binding domain.Bone. 2019 Jun;123:153-158. doi: 10.1016/j.bone.2019.03.028. Epub 2019 Mar 23. Bone. 2019. PMID: 30914275 Free PMC article.
-
A novel TRPS1 mutation in a Moroccan family with Tricho-rhino-phalangeal syndrome type III: case report.BMC Med Genet. 2017 May 3;18(1):50. doi: 10.1186/s12881-017-0413-8. BMC Med Genet. 2017. PMID: 28468609 Free PMC article.
-
Case report: A novel mutation in TRPS1 identified in a Chinese family with tricho-rhino-phalangeal syndrome I: A therapeutic challenge.Front Pediatr. 2022 Nov 18;10:990230. doi: 10.3389/fped.2022.990230. eCollection 2022. Front Pediatr. 2022. PMID: 36467473 Free PMC article.
-
Recombinant Human Growth Hormone Therapy for Childhood Trichorhinophalangeal Syndrome Type I: A Case Report.Children (Basel). 2022 Sep 22;9(10):1447. doi: 10.3390/children9101447. Children (Basel). 2022. PMID: 36291383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
